facebook
eISSN: 2084-9893
ISSN: 0033-2526
Dermatology Review/Przegląd Dermatologiczny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2024
vol. 111
 
Share:
Share:
abstract:
Special paper

Polish guidelines for the diagnosis and treatment of hidradenitis suppurativa

Łukasz Matusiak
1
,
Irena Walecka
2
,
Adam Reich
3
,
Andrzej Bieniek
1
,
Dorota Krasowska
4
,
Wioletta Barańska-Rybak
5
,
Beata Bergler-Czop
6
,
Aleksandra Lesiak
7
,
Joanna Narbutt
7
,
Agnieszka Owczarczyk-Saczonek
8
,
Witold Owczarek
9
,
Jacek Szepietowski
1

  1. Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland
  2. Department of Dermatology, Centre of Postgraduate Medical Education/National Medical Institute of the Ministry of the Interior and Administration, Warsaw, Poland
  3. Department of Dermatology, Institute of Medical Sciences, College of Medical Sciences, University of Rzeszow, Rzeszow, Poland
  4. Department of Dermatology, Venereology and Paediatric Dermatology, Medical University of Lublin, Lublin, Poland
  5. Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, Gdansk, Poland
  6. Department of Dermatology, Medical University of Silesia, Katowice, Poland
  7. Department of Dermatology, Paediatric and Oncologic Dermatology, Medical University of Lodz, Lodz, Poland
  8. Department of Dermatology, Sexually Transmitted Diseases and Clinical Immunology, University of Warmia and Mazury, Olsztyn, Poland
  9. Department of Dermatology, Military Institute of Medicine, Warsaw, Poland
Dermatol Rev/Przegl Dermatol 2024, 111, 1-19
Online publish date: 2024/06/28
View full text Get citation
 
PlumX metrics:
Hidradenitis suppurativa is a chronic, recurrent, inflammatory skin disease that affects hair follicles, typically developing after puberty. It is characterized by painful, deep-seated inflammatory lesions that appear in anatomical regions where apocrine glands are located, mainly in the axillar, inguinal, and anogenital areas. The pathogenesis of hidradenitis suppurativa is multifactorial, with follicular occlusion representing the initial stage of the disease and subsequently leading to the formation of neutrophilic abscesses and infiltration by various inflammatory cells. The treatment of hidradenitis suppurativa requires a multidisciplinary approach, involving dermatologists and dermatologic surgeons, as well as physicians of other medical specialties. The primary pharmacological treatments for hidradenitis suppurativa involve antibiotics and biologic disease-modifying drugs, which can be used either in monotherapy or in combination with surgical interventions. The following guidelines provide up-to-date information on the management of patients with hidradenitis suppurativa.
keywords:

hidradenitis suppurativa, guidelines, treatment, diagnostics



Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.